Share

    


In This Section

Home / Archived Webinar Details

Webinar: CAR T-Cell Therapy: What We Know (and Don’t Know) 1 Year Later

Join the ACCC Immuno-Oncology Institute for a live webinar on the nuances of chimeric antigen (CAR) T-cell therapy, including appropriate patient selection, referral coordination, and communication among members of the multidisciplinary cancer care team.

View On-Demand Replay

Learning Objectives

  • Understand the current and future applicability of CAR T-cell therapy
  • Identify barriers and solutions related to patient referrals to cancer centers delivering CAR T-cell therapy
  • Optimize appropriate patient selection for CAR T-cell therapy
  • Utilize strategies to recognize and manage toxicities related to CAR T-cell therapy

Faculty:

  • Murali Janakiram, MD
    Assistant Professor of Medicine, Attending Physician, Division of Hematological Malignancies / Bone Marrow Transplant, Dept of Oncology
    Montefiore Medical Center/Albert Einstein College of Medicine
  • Elsa M. Delille, MSN, FNP-BC
    Nurse Practitioner, Blood and Marrow Transplantation and Cell Therapy Program
    Columbia University Medical Center
  • Ran Reshef, MD MSc
    Associate Professor of Medicine; Director, Translational Research, Blood and Marrow Transplantation and Cell Therapy Program, Division of Hematology/Oncology and Columbia Center for Translational Immunology
    Columbia University Medical Center
  • Karen G. Wright, RN-BC, MS, OCN, BMTCN
    Nurse, Bone Marrow and Cellular Immunotherapy
    Montefiore Medical Center/Albert Einstein College of Medicine